Middleton, M. R., & Schadendorf, D. (2016). Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. Journal of clinical oncology, 18(1), . https://doi.org/10.1200/JCO.2000.18.1.158
Chicago-Zitierstil (17. Ausg.)Middleton, Mark R., und Dirk Schadendorf. "Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients with Advanced Metastatic Malignant Melanoma." Journal of Clinical Oncology 18, no. 1 (2016). https://doi.org/10.1200/JCO.2000.18.1.158.
MLA-Zitierstil (9. Ausg.)Middleton, Mark R., und Dirk Schadendorf. "Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients with Advanced Metastatic Malignant Melanoma." Journal of Clinical Oncology, vol. 18, no. 1, 2016, https://doi.org/10.1200/JCO.2000.18.1.158.